Prelude Therapeutics to Present at the H.C. Wainwright BioConnect Virtual Conference

Prelude Therapeutics

WILMINGTON, DE — Prelude Therapeutics Inc. (Nasdaq: PRLD) announced that Kris Vaddi, Ph.D., Chief Executive Officer, will present at the H.C Wainwright BioConnect Virtual Conference, being held on January 10-13, 2022.

The prerecorded presentation will become available on Monday, January 10, 2022, at 7:00 am ET and can be accessed by visiting the “Investors” page under the “Events & Presentation” section of the Prelude website, where a replay of the presentation will be available for a limited time.

Prelude Therapeutics is a clinical-stage precision oncology company developing innovative, potential best-in-class molecules targeting critical cancer cell pathways involved in cancer pathogenesis.

Thanks for visiting! MyChesCo brings reliable information and resources to Chester County, Pennsylvania. Please consider supporting us in our efforts. Your generous donation will help us continue this work and keep it free of charge. Show your support today by clicking here and becoming a patron.